EXACT Sciences Corporation

Diagnostics & Research

Prices are adjusted according to historical splits.

EXACT Sciences Corporation Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$11.79 billion
Book Value:
Revenue TTM:
$2.08 billion
Operating Margin TTM:
Gross Profit TTM:
$1.51 billion
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

EXACT Sciences Corporation had its IPO on 2001-02-01 under the ticker symbol EXAS.

The company operates in the Healthcare sector and Diagnostics & Research industry. EXACT Sciences Corporation has a staff strength of 6,300 employees.

Stock update

Shares of EXACT Sciences Corporation opened at $65.35 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $63.14 - $65.46, and closed at $63.44.

This is a -4.1% slip from the previous day's closing price.

A total volume of 2,961,300 shares were traded at the close of the day’s session.

In the last one week, shares of EXACT Sciences Corporation have slipped by -1.98%.

EXACT Sciences Corporation's Key Ratios

EXACT Sciences Corporation has a market cap of $11.79 billion, indicating a price to book ratio of 2.603 and a price to sales ratio of 3.9532.

In the last 12-months EXACT Sciences Corporation’s revenue was $2.08 billion with a gross profit of $1.51 billion and an EBITDA of $-423356992. The EBITDA ratio measures EXACT Sciences Corporation's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, EXACT Sciences Corporation’s operating margin was -29.79% while its return on assets stood at -6.01% with a return of equity of -19.39%.

In Q4, EXACT Sciences Corporation’s quarterly earnings growth was a positive 0% while revenue growth was a positive 16.7%.

EXACT Sciences Corporation’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-3.48 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of -1.07. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into EXACT Sciences Corporation’s profitability.

EXACT Sciences Corporation stock is trading at a EV to sales ratio of 4.9219 and a EV to EBITDA ratio of -18.9372. Its price to sales ratio in the trailing 12-months stood at 3.9532.

EXACT Sciences Corporation stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$6.23 billion
Total Liabilities
$412.75 million
Operating Cash Flow
Capital Expenditure
$72.88 million
Dividend Payout Ratio

EXACT Sciences Corporation ended 2023 with $6.23 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $6.23 billion while shareholder equity stood at $3.04 billion.

EXACT Sciences Corporation ended 2023 with $0 in deferred long-term liabilities, $412.75 million in other current liabilities, 1780000.00 in common stock, $-3265026000.00 in retained earnings and $2.35 billion in goodwill. Its cash balance stood at $242.49 million and cash and short-term investments were $632.06 million. The company’s total short-term debt was $28,366,000 while long-term debt stood at $2.19 billion.

EXACT Sciences Corporation’s total current assets stands at $982.26 million while long-term investments were $0 and short-term investments were $389.56 million. Its net receivables were $158.04 million compared to accounts payable of $74.92 million and inventory worth $118.26 million.

In 2023, EXACT Sciences Corporation's operating cash flow was $-58159000.00 while its capital expenditure stood at $72.88 million.

Comparatively, EXACT Sciences Corporation paid $0 in dividends in 2023.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

EXACT Sciences Corporation stock is currently trading at $63.44 per share. It touched a 52-week high of $76.94 and a 52-week low of $76.94. Analysts tracking the stock have a 12-month average target price of $72.06.

Its 50-day moving average was $64.56 and 200-day moving average was $47.16 The short ratio stood at 6.12 indicating a short percent outstanding of 0%.

Around 91.7% of the company’s stock are held by insiders while 9040.8% are held by institutions.

Frequently Asked Questions About EXACT Sciences Corporation

The stock symbol (also called stock or share ticker) of EXACT Sciences Corporation is EXAS

The IPO of EXACT Sciences Corporation took place on 2001-02-01

Similar Industry Stocks (Diagnostics & Research)

Last Price

Most Active

Last Price

Top Gainers

Last Price

Top Losers

Last Price


Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company’s pipeline products focus on enhancing the Cologuard test’s performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.


5505 Endeavor Lane, Madison, WI, United States, 53719